2020 News November 16, 2020 Nymox Provides Update on

New Post Public Reply Private Reply Replies (0) Message Board
znewcar1
267
2020 News
November 16, 2020
Nymox Provides Update on Regulatory Filing Activities
Nymox Pharmaceutical Corporation is pleased to provide a current update on the regulatory filing status for Fexapotide Triflutate (FT), Nymox's first in class lead product for the treatment of benign prostatic hyperplasia (BPH). Substantial progress has been made and there are no material changes to the content of the planned applications.

Download
August 12, 2020
Nymox Announces $9 Million Registered Direct Offering
Nymox Pharmaceutical Corporation today announced it has entered into definitive agreements with institutional and accredited investors for the purchase and sale of shares of its common stock.

Download
July 28, 2020
NYMOX Provides Current Update on Key Company Developments
Nymox Pharmaceutical Corporation is pleased to report current updates on the Company's most important ongoing developments.

Download
June 19, 2020
Nymox Announces Updates in Regulatory Submissions For Fexapotide Treatment For Prostate Enlargement
Nymox Pharmaceutical Corporation is very pleased to report that key steps in its regulatory submission preparations have been completed and the project is firmly on-track.

Download
April 21, 2020
Nymox Announces Important New Patent Developments
Nymox Pharmaceutical Corporation is pleased to announce the recent allowances of 4 new different US and international patents concerning the Company's prostate enlargement and prostate cancer treatments.

Download
February 24, 2020
Nymox Announces New Peer Review Publication of Prostate Cancer Fexapotide Clinical Trial Results in World Journal of Urology
Nymox Pharmaceutical Corporation is pleased to announce that a new peer review report was published today in the World Journal of Urology, documenting the successful long-term clinical trial results after Fexapotide Triflutate treatment for early stage prostate cancer.

Download
February 6, 2020
Nymox Announces New Appointment of Russell Thomson Ph.D. as Nymox Vice President of Quality and Regulatory Affairs
Nymox Pharmaceutical Corporation is pleased to announce the new appointment of Russell I. Thomson PhD, FRSC to the position of Nymox Vice President of Quality and Regulatory Affairs. Dr Thomson is an authority in the field of Quality Assurance and Control in the chemical and pharmaceutical industries.

Download
January 28, 2020
Nymox Provides Update on Current Corporate Activities and Milestones
Nymox Pharmaceutical Corporation is pleased to provide a current January 2020 update on several important corporate activities and achievements since the last update in October 2019.

Download
January 6, 2020
Nymox Announces New Peer Review Article on Fexapotide Pharmaco-Ablation Experimental Studies Published in Research and Reports in Urology
Nymox Pharmaceutical Corporation is pleased to report a new peer review research report has been published on experimental studies of the Company's Fexapotide Triflutate treatment for prostate enlargement (BPH) and low grade prostate cancer. The article is entitled "Fexapotide triflutate induces selective prostate glandular pharmaco-ablation in the rat" and it is published in Research and Reports in Urology.

Nymox Pharmaceutical Corp. (NYMX) Stock Research Links

NYMX Board Company Profile Buy Rating Time & Sales News Filings Financials
The majority of my post are the top 20% gainer! To decode them its (ticker ID, % Changed, Volume, Close price and Float) I typically put V,C&F as a prefix to that number and use K, M and B as a suffix (Kilo, Million & Billion) for volume and float. I may also use S for Support and R for Resistance.

I (Znewcar1) do not provide personal investment advice and I am not a qualified licensed investment advisor. I am an amateur investor.
All information found here, including any ideas, opinions, views, predictions, forecasts, commentaries, suggestions, or stock picks, expressed or implied herein, are for informational, entertainment or educational purposes only and should not be construed as personal investment advice. While the information provided is believed to be accurate, it may include errors or inaccuracies.
I will not and cannot be held liable for any actions you take as a result of anything you read here.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Samsung Biologics' Big Gains and Ambitious Moves in 2026

Updated Category News Views 6

A Robust Third Quarter Samsung Biologics is making some serious noise in the biopharma sector with its latest Q3 2026 financial results. We're talking about KRW 1,490 billion in revenue, an uptick that screams growth, backed by an operating profit of KRW 640 billion. What's fueling this engine? Their relentless plant expansion and a pivotal step into the U.S. market....

Continue Reading
Jarrard Amplifies Healthcare Influence with D.C. Move

Updated Category News Views 5

Strategic Shift to the Heart of Policy When a healthcare advisory firm decides to root itself in the epicenter of American politics, you know they're gearing up for more than just casual conversation. Jarrard's leap into Washington, D.C. isn't just a relocation—it's an amplification of influence in the complex world of healthcare policy. This move, accentuated by the...

Continue Reading
McLean Guide: Turning Culture Data into Real Action

Updated Category News Views 0

Unlocking the Potential of Culture Measurement In the corporate jungle, culture is like oxygen. You don’t see it, but you sure as heck feel it when it’s missing or toxic. McLean & Company just dropped a new guide that promises to map out the invisible by measuring organizational culture. Now, you might say, 'Cultural alignment sounds like consultant mumbo-jumbo.' But...

Continue Reading
Ashford Hospitality Trust: Fee Waiver and Share Buyback

Updated Category News Views 3

Strategic Moves in a Challenging Market When it rains, it pours. Ashford Hospitality Trust (NYSE: AHT), the real estate investment trust that's got its fingers in the hotel industry pie, is shaking things up with some bold maneuvers. The company just dropped a bombshell: it's waiving a $17 million advisory fee, buying back shares, and terminating its at-the-market (ATM)...

Continue Reading
NEXT Properties' Exchange Offer Sees Strong Participation

Updated Category News Views 7

NEXT Properties Makes Bold Moves with Exchange Offers NEXT Properties has pulled the trigger on a massive swap of its notes, and it's a tale investors should tune into. They're swapping out their old notes like a veteran trader ditching penny stocks for blue chips. It’s an intriguing maneuver—risk-laden yet foreboding to anyone who knows the game. Breaking Down the...

Continue Reading
AEVEX Faces Legal Scrutiny Amid Secondary Offering Stir

Updated Category News Views 10

AEVEX on the Legal Hook: What's Going Down? Look, nobody likes bad news, especially when their pockets feel the pinch. AEVEX Corp. (NYSE: AVEX) kicked up quite the dust cloud when their stock plummeted after a secondary offering—dropping a whopping 16% at first glance, and then an extra seven in the blink of an eye. Timing Is Everything in the Stock Game Set the stage:...

Continue Reading
BRAC Bank Taps Finastra for Trade Finance Transformation

Updated Category News Views 10

Bangladesh's BRAC Bank Embarks on Tech Transformation If ever there was a time for a bank to shake things up, BRAC Bank in Bangladesh decided it's now. Partnering up with Finastra, they're on a mission to modernize their trade finance operations, and they're banking on these changes to keep them relevant and competitive in a shaky global economy. Streamlining Trade...

Continue Reading
New Wealth Firm Iron Shore Offers Tailored Financial Advising

Updated Category News Views 7

A Fresh Take on Wealth Management This isn't your average wealth management spiel folks; it's something that's trying to give the old dusty models a shake-up. Kamar Plunkett and Shara Thomas have thrown their hats into the ring with Iron Shore Wealth Strategies. Anyone tuning into this financial soap opera would appreciate this pivot—because hey, when was the last time...

Continue Reading
Hyliion Faces Legal Drama Over Securities Violations

Updated Category News Views 4

A Stock Tango Entangled in Legal Webs Ah, Hyliion Holdings Corp. (NYSE American: HYLN) finds itself in the legal crosshairs this time around. On October 20, 2026, DJS Law Group sounded the alarm, reminding investors that there’s a class action lawsuit hanging over Hyliion's head like a gray cloud over a picnic. Allegations of securities law violations are the game of...

Continue Reading
Digital Health Excellence: 14 Systems Earn Top Honors

Updated Category News Views 5

The pace at which healthcare is embracing digital transformation makes one's head spin these days. Fourteen organizations just hit the jackpot of sorts—the 2026 CHIME Digital Health Most Wired survey awarded them the highest honor, Level 10. This ain't just some participation trophy; it's the real deal, putting a spotlight on organizations that aren't merely dabbling in...

Continue Reading

Top 5 Most Recently Viewed Articles

Empowering Future Entrepreneurs at the HLF International Startups Day

Updated Category News Views 101

HLF International Startups Day Highlights Innovation and Resilience In today's rapidly evolving world, where global supply chains are undergoing significant changes and climate-related issues become more pressing, startups are emerging as pivotal players in crafting resilient futures. At the recent HLF International Startups Day, hosted as part of the 2024 High Level...

Continue Reading
Treasury Bills Auction Results: January Insights and Trends

Updated Category News Views 427

Results of Recent Treasury Bills Auction The recent auction of treasury bills has shown significant activity, revealing essential insights for investors and analysts alike. On January 15th, expectations were met as bids, sales, and other key financial metrics showcased a dynamic marketplace. Key Statistics from the Auction During this auction, detailed information...

Continue Reading
Closinglock Attracts $34 Million Series B Funding for Growth

Updated Category News Views 161

Closinglock Secures Significant Series B Funding Closinglock, a prominent provider of fintech solutions focused on the real estate sector, recently announced the successful closure of a $34 million Series B funding round. The investment round was led by Sageview Capital, with additional support from Headline and RWT Horizons. This financial boost is set to elevate...

Continue Reading
Vestaron Secures Over $20 Million to Boost Bioinsecticide Launch

Updated Category News Views 305

Vestaron Secures Major Funding to Propel Bioinsecticide Innovations In a significant step towards revolutionizing crop protection, Vestaron has successfully closed a funding round exceeding $20 million. This investment not only underscores the confidence investors have in Vestaron's groundbreaking peptide technology but also aims to expedite its market entry for...

Continue Reading
NXP Semiconductors Plans Earnings Call for Q4 and Full Year 2024

Updated Category News Views 169

NXP Semiconductors Announces Upcoming Financial Conference Call NXP Semiconductors N.V. (NASDAQ: NXPI) has exciting news as they prepare to discuss their financial results for the fourth quarter and the full year of 2024. The eagerly awaited announcement will take place after the close of business on the NASDAQ Global Select Market. This significant moment is scheduled...

Continue Reading